Safety of Administering Isoniazid to SLE Patients to Prevent TB

Clinical trial NCT06618573 · RECRUITING

Trial details

NCT number: NCT06618573
Sponsor: Universitas Padjadjaran
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberculosis Systemic Lupus Erythematosus

Start date: 2022-08-15
Primary completion: 2025-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.